Since GLP-1 RAs are often prescribed to patients with obesity, this single unmeasured factor could be the true driver of the observed risk. Demetrios Vavvas, MD, PhD Second, the results may be influenced by surveillance bias, Vavvas continued
Here is how the economics typically break down
Most insulin syringes are designed for single use: draw from the vial, inject, dispose
My dishwasher isn't, my electric car that I'm sitting in while typing this and NOT letting emissions into the air isn't, texting instead of writing hand-written letters, airplanes instead of boats like the Titanic to go cross-Atlantic, and here's where I really get unfiltered don't come after me: smallpox vaccine
It also reduces appetite, often resulting in weight loss
Heart Health and Cardiovascular Protection Several large clinical trials have shown that GLP-1 receptor agonists reduce the risk of major cardiovascular events